MD or RVTY: Which Is the Better Value Stock Right Now?

Core Insights - The article compares two medical services stocks, Pediatrix Medical Group (MD) and Revvity (RVTY), to determine which offers better value for investors [1] Valuation Metrics - Pediatrix Medical Group has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Revvity has a Zacks Rank of 3 (Hold) [3] - MD has a forward P/E ratio of 8.04, significantly lower than RVTY's forward P/E of 25.15, suggesting MD is undervalued [5] - The PEG ratio for MD is 1.81, compared to RVTY's 2.83, indicating MD's expected earnings growth is more favorable [5] - MD's P/B ratio is 1.17, while RVTY's P/B ratio is 1.87, further supporting MD's valuation as more attractive [6] - Based on these metrics, MD receives a Value grade of A, while RVTY is rated C, highlighting MD's superior value proposition [6] Earnings Outlook - MD is noted for its improving earnings outlook, which enhances its attractiveness in the Zacks Rank model [7]